Literature DB >> 8476848

Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia.

R J Olds1, D A Lane, V Chowdhury, V De Stefano, G Leone, S L Thein.   

Abstract

Antithrombin is the principle regulator of thrombin and other blood coagulation proteinases. It is a member of the serpin family of proteinase inhibitors. The genomic sequence of the antithrombin locus has been completed, revealing a gene spanning 13,477 base pairs from the transcription start site to the poly(A) addition signal. Nine complete and one partial Alu repeat elements were identified within the introns of the gene, with all but one orientated in the reverse direction. Inherited deficiency of antithrombin is associated with a venous thrombotic tendency. Restriction fragment mapping of the antithrombin genes in an individual with type I antithrombin deficiency identified an intragenic deletion in one allele. Localization of the deletion breakpoints involved restriction analysis and direct sequencing of amplified DNA spanning the deletion site. The deletion removed 2761 base pairs, affecting exon 5 and flanking introns, with the deletion ends contained within the left components of two Alu elements. It is likely, therefore, that the deletion arose by homologous recombination between the two Alu elements.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476848     DOI: 10.1021/bi00067a008

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  A novel 5'-upstream mutation in the factor XII gene is associated with a TaqI restriction site in an Alu repeat in factor XII-deficient patients.

Authors:  S Hofferbert; J Müller; H Köstering; W D von Ohlen; M Schloesser
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

2.  Ligand-dependent enhancement of human antithrombin gene expression by retinoid X receptor alpha and thyroid hormone receptor beta.

Authors:  R W Niessen; F Rezaee; P H Reitsma; M Peters; J J de Vijlder; A Sturk
Journal:  Biochem J       Date:  1996-08-15       Impact factor: 3.857

3.  Normal ranges and genetic variants of antithrombin, protein C and protein S in the general Chinese population. Results of the Chinese Hemostasis Investigation on Natural Anticoagulants Study I Group.

Authors:  Tienan Zhu; Qiulan Ding; Xia Bai; Xiaoyan Wang; Florentia Kaguelidou; Corinne Alberti; Xuqian Wei; Baolai Hua; Renchi Yang; Xuefeng Wang; Zhaoyue Wang; Changgeng Ruan; Nicole Schlegel; Yongqiang Zhao
Journal:  Haematologica       Date:  2011-04-12       Impact factor: 9.941

4.  Two novel gene mutations in type I antithrombin deficiency.

Authors:  K Niiya; T Kiguchi; H Dansako; K Fujimura; T Fujimoto; K Iijima; M Tanimoto; M Harada
Journal:  Int J Hematol       Date:  2001-12       Impact factor: 2.490

Review 5.  Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism.

Authors:  S M Bates; J S Ginsberg; S E Straus; H Rekers; D L Sackett
Journal:  CMAJ       Date:  2000-10-17       Impact factor: 8.262

6.  Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency.

Authors:  Véronique Picard; Jian-Min Chen; Brigitte Tardy; Marie-Françoise Aillaud; Christine Boiteux-Vergnes; Marie Dreyfus; Joseph Emmerich; Cécile Lavenu-Bombled; Ulrike Nowak-Göttl; Nathalie Trillot; Martine Aiach; Martine Alhenc-Gelas
Journal:  Hum Genet       Date:  2009-09-17       Impact factor: 4.132

7.  Five novel and four recurrent point mutations in the antithrombin gene causing venous thrombosis.

Authors:  Keiko Nagaizumi; Hiroshi Inaba; Kagehiro Amano; Midori Suzuki; Morio Arai; Katsuyuki Fukutake
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

8.  Glutathione S-transferase and S-crystallins of cephalopods: evolution from active enzyme to lens-refractive proteins.

Authors:  S I Tomarev; S Chung; J Piatigorsky
Journal:  J Mol Evol       Date:  1995-12       Impact factor: 2.395

9.  Antithrombin III: summary of first database update.

Authors:  D A Lane; R J Olds; S L Thein
Journal:  Nucleic Acids Res       Date:  1994-09       Impact factor: 16.971

10.  A complex genomic abnormality found in a patient with antithrombin deficiency and autoimmune disease-like symptoms.

Authors:  Io Kato; Yuki Takagi; Yumi Ando; Yuki Nakamura; Moe Murata; Akira Takagi; Takashi Murate; Tadashi Matsushita; Tadaaki Nakashima; Tetsuhito Kojima
Journal:  Int J Hematol       Date:  2014-06-03       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.